Cuardaigh le haghaidh roghanna malartacha:
"program implementing" » "from implementing" (Leathnaigh an cuardach)
"program implementinging" » "from implementinging" (Leathnaigh an cuardach)
"program implementinged" » "from implementinged" (Leathnaigh an cuardach), "program implemented" (Leathnaigh an cuardach), "program implementingrules" (Leathnaigh an cuardach)
161 - 180 toradh á dtaispeáint as 442 toradh san iomlán ar an gcuardach '(("program implementing") OR ((("program implementinging") OR ("program implementinged"))))', am iarratais: 0.19s Beachtaigh na torthaí
  1. 161
    Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal.

    Percent difference in expected and observed incidence of Japanese encephalitis following vaccination campaign, by district, Nepal. de réir Shyam Raj Upreti (4451614)

    Foilsithe / Cruthaithe 2017
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 162
    Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377).

    Characteristics of confirmed invasive pneumococcal disease cases reported in Ontario, Canada, 2007–2017 (N = 12,377). de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 163
    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type<sup>a</sup> and age group, in Ontario, Canada, 2007-2017<sup>b</sup>.

    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by year, associated vaccine type<sup>a</sup> and age group, in Ontario, Canada, 2007-2017<sup>b</sup>. de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 164
    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017.

    Incidence rates (per 100,000 population) of invasive pneumococcal disease, by age group and year, in Ontario, Canada, 2007–2017. de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 165
    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017.

    Serotype distribution of invasive pneumococcal disease cases<sup>a</sup>, by associated vaccine type, in Ontario, Canada, 2007–2017. de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 166
    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377).

    Number of confirmed invasive pneumococcal disease cases, by associated vaccine type<sup>a</sup> and year, in Ontario, Canada, 2007–2017 (N = 12,377). de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 167
    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017.

    Incidence rates (per 100,000 population) of commonly<sup>a</sup> reported <i>S</i>. <i>pneumoniae</i> serotypes in Ontario, Canada, by year: 2007–2017. de réir Shinthuja Wijayasri (8124539)

    Foilsithe / Cruthaithe 2019
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 168
    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    VIA findings at first screening by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). de réir Abigail K. Korn (12096012)

    Foilsithe / Cruthaithe 2022
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 169
    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020).

    Same day cryotherapy/thermocoagulation performed by HIV status in Namibia (October 2018 –March 2020). de réir Abigail K. Korn (12096012)

    Foilsithe / Cruthaithe 2022
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 170
    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020).

    Treatment for cervical pre-cancer lesions and post-treatment complications by age, lesion severity, and HIV status in Namibia (October 2018–March 2020). de réir Abigail K. Korn (12096012)

    Foilsithe / Cruthaithe 2022
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 171
    Participant demographics.

    Participant demographics. de réir Nickolas D. Zaller (8727462)

    Foilsithe / Cruthaithe 2020
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 172
    Characteristics of participants at baseline of community ART group.

    Characteristics of participants at baseline of community ART group. de réir Patrick Dakum (364901)

    Foilsithe / Cruthaithe 2021
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 173
    Summary of council demographics and geography.

    Summary of council demographics and geography. de réir Castory Munishi (9308105)

    Foilsithe / Cruthaithe 2023
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 174
    Total cost of referrals completed for FY2020/21.

    Total cost of referrals completed for FY2020/21. de réir Castory Munishi (9308105)

    Foilsithe / Cruthaithe 2023
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 175
    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system.

    The decision tree comparing the cost and effectiveness of the standard referral system and the emergency transport system. de réir Castory Munishi (9308105)

    Foilsithe / Cruthaithe 2023
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 176
    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up.

    Differences in the participants’ bodyweight, immunologic and virologic status after a year follow-up. de réir Patrick Dakum (364901)

    Foilsithe / Cruthaithe 2021
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 177
    Summary of test results after one year of follow-up.

    Summary of test results after one year of follow-up. de réir Patrick Dakum (364901)

    Foilsithe / Cruthaithe 2021
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 178
    Mean of completed referrals for FY 2020/2021.

    Mean of completed referrals for FY 2020/2021. de réir Castory Munishi (9308105)

    Foilsithe / Cruthaithe 2023
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 179
    Summary of undiscounted cost and effectiveness for Shinyanga region.

    Summary of undiscounted cost and effectiveness for Shinyanga region. de réir Castory Munishi (9308105)

    Foilsithe / Cruthaithe 2023
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 180
    Summary of test uptake against results after one year of follow-up.

    Summary of test uptake against results after one year of follow-up. de réir Patrick Dakum (364901)

    Foilsithe / Cruthaithe 2021
    Ábhair:
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: